You have 9 free searches left this month | for more free features.

Dose confirmation

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Small Cell Lung Carcinoma (SCLC) Trial (BI 764532, Topotecan)

Not yet recruiting
  • Small Cell Lung Carcinoma (SCLC)
  • (no location specified)
Aug 7, 2023

Influenza, Human Trial (Flu mRNA, Control 1, Control 2)

Not yet recruiting
  • Influenza, Human
  • Flu mRNA
  • +2 more
  • (no location specified)
Apr 21, 2023

Hemophilia B Trial in Los Angeles (verbrinacogene setparvovec)

Recruiting
  • Hemophilia B
  • verbrinacogene setparvovec
  • Los Angeles, California
    Children's Hospital of Los Angeles
Jan 7, 2022

Warm Autoimmune Hemolytic Anemia Trial (Obexelimab, Placebo)

Not yet recruiting
  • Warm Autoimmune Hemolytic Anemia
  • (no location specified)
Mar 24, 2023

Advanced Solid Tumor Trial in China (IO-108, IO-108 + pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumor
  • IO-108
  • IO-108 + pembrolizumab
  • Changsha, Hunan, China
  • +3 more
Aug 18, 2022

Oral Cavity Squamous Cell Carcinoma Trial in San Francisco (NisinZ® P, Surgery (non-interventional, standard of care))

Not yet recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • NisinZ® P
  • Surgery (non-interventional, standard of care)
  • San Francisco, California
    University of California, San Francisco
Oct 18, 2023

MDS, Secondary Acute Myeloid Leukemia (AML) Trial in United States (Clofarabine)

Completed
  • Myelodysplastic Syndromes
  • Secondary Acute Myeloid Leukemia (AML)
  • Chicago, Illinois
  • +5 more
Mar 15, 2022

Coronavirus, Covid19, SARS-CoV-2 Trial in Panama city, Lima (CVnCoV 6 µg, CVnCoV 12 µg, Hepatitis A vaccine)

Completed
  • Coronavirus
  • +3 more
  • CVnCoV 6 μg
  • +4 more
  • Panama city, Panama
  • +1 more
Mar 9, 2022

Hemophilia B Trial in United States (AAV5-hFIXco-Padua (AMT-061))

Active, not recruiting
  • Hemophilia B
  • AAV5-hFIXco-Padua (AMT-061)
  • Los Angeles, California
  • +3 more
May 17, 2022

BK Virus Infection, Nephropathy, Kidney Transplantation Trial in Australia, Japan, Korea, Republic of (Brincidofovir)

Not yet recruiting
  • BK Virus Infection
  • +2 more
  • Adelaide, Australia
  • +9 more
Aug 22, 2022

NSCLC Trial in Budapest, Gyongyos (BNT116, Cemiplimab, Docetaxel)

Recruiting
  • Non-Small Cell Lung Cancer
  • BNT116
  • +2 more
  • Baltimore, Maryland
  • +14 more
Dec 19, 2022

Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2, LGMD2I Trial (LION-101 dose level 1, LION-101 dose level

Not yet recruiting
  • Limb Girdle Muscular Dystrophy
  • +8 more
  • LION-101 dose level 1
  • +2 more
  • (no location specified)
Feb 17, 2022

Adenovirus Infection Trial in United States (BCV)

Recruiting
  • Adenovirus Infection
  • Los Angeles, California
  • +10 more
May 24, 2022

Metastatic Ovarian Cancer, Triple Negative Breast Cancer Trial in Re?ovot (Nerofe is a first in class derivative of a human

Withdrawn
  • Metastatic Ovarian Cancer
  • Triple Negative Breast Cancer
  • Nerofe is a first in class derivative of a human hormon-peptide(TCApF), with Cancer suppressive properties.
  • Reẖovot, Israel
    Oncologic Institue, Kaplan
Oct 18, 2021

Zika Virus Trial in Puerto Rico, United States (mRNA-1893, Placebo)

Active, not recruiting
  • Zika Virus
  • mRNA-1893
  • Placebo
  • Sioux City, Iowa
  • +10 more
Aug 31, 2022

Colorectal Cancer, MSS, Stage IV Colon Cancer Trial in Belgium, Switzerland, United States (ATP128, BI 754091, VSV-GP128)

Recruiting
  • Colorectal Cancer
  • +5 more
  • Scottsdale, Arizona
  • +10 more
Aug 15, 2022

Influenza, Human Trial in United States (NanoFlu (Quad-NIV), Matrix-M Adjuvant, Placebo)

Terminated
  • Influenza, Human
  • NanoFlu (Quad-NIV)
  • +5 more
  • Hollywood, Florida
  • +13 more
Nov 3, 2022

Multiple Myeloma, Relapse Multiple Myeloma Trial in Ramat Gan (CAR-BCMA)

Recruiting
  • Multiple Myeloma
  • Relapse Multiple Myeloma
  • CAR-BCMA
  • Ramat Gan, Israel
    Chaim Sheba Medical Center, Tel Hashomer
Feb 7, 2022

Myelodysplastic Syndrome, MDS Trial in Canada, United States (ASTX727 Dose Escalation, ASTX727 Dose Confirmation, ASTX727

Completed
  • Myelodysplastic Syndrome
  • MDS
  • ASTX727 Dose Escalation
  • +2 more
  • Phoenix, Arizona
  • +16 more
Dec 1, 2020

Sinusitis, Acute Trial in Cohoes (Amoxicillin 875 mg, Placebo (lactase))

Terminated
  • Sinusitis, Acute
  • Amoxicillin 875 mg
  • Placebo (lactase)
  • Cohoes, New York
    Albany Medical Center Internal Medicine and Pediatrics
Jul 19, 2021

Metastatic Breast Cancer Trial in Bulgaria, Russian Federation, United Kingdom (Eribulin mesylate, Capecitabine)

Completed
  • Metastatic Breast Cancer
  • Pleven, Bulgaria
  • +9 more
Jan 6, 2021

Influenza, Human Trial in United States (Experimental: IIV-A Investigational IIV-A will be administered as a single dose

Not yet recruiting
  • Influenza, Human
  • Experimental: IIV-A Investigational IIV-A will be administered as a single dose intramuscularly on Day 1
  • +3 more
  • Tempe, Arizona
  • +44 more
Aug 16, 2022

Melanoma (Skin), Non-Small-Cell Lung Carcinoma Trial in Belgium, Spain, United Kingdom (GAd-PEV, MVA-PEV)

Recruiting
  • Melanoma (Skin)
  • Non-Small-Cell Lung Carcinoma
  • GAd-PEV
  • MVA-PEV
  • Charleroi, Belgium
  • +6 more
Feb 23, 2022

Lymphoma, Large B-Cell, Diffuse (DLBCL) Trial in Jerusalem, Seoul, Warszawa (Zilovertamab Vedotin, Cyclophosphamide,

Recruiting
  • Lymphoma, Large B-Cell, Diffuse (DLBCL)
  • Zilovertamab Vedotin
  • +6 more
  • Victoria, British Columbia, Canada
  • +19 more
Jan 19, 2023

Gastro-Enteropancreatic Neuroendocrine Tumor Trial in Austria, Denmark, United States (Satoreotide trizoxetan 5-20µg,

Completed
  • Gastro-Enteropancreatic Neuroendocrine Tumor
  • Satoreotide trizoxetan 5-20μg
  • Satoreotide trizoxetan 30-45μg
  • Los Angeles, California
  • +4 more
Jan 8, 2021